1585P Performance status restrictions in clinical trials leading to US food and drug administration (FDA) drug approval: A cross-sectional study of a decade (2014-2023).
Saved in:
| Title: | 1585P Performance status restrictions in clinical trials leading to US food and drug administration (FDA) drug approval: A cross-sectional study of a decade (2014-2023). |
|---|---|
| Authors: | Iannantuono, G.M.1 (AUTHOR), Filetti, M.1 (AUTHOR), Giudice, E.2 (AUTHOR), Sganga, S.3 (AUTHOR), Chandran, E.B.A.4 (AUTHOR), Xue, E.5 (AUTHOR), Lombardi, P.6 (AUTHOR), Rosenfeld, R.7 (AUTHOR), Rapisarda, E.8 (AUTHOR), Ferri, L.9 (AUTHOR), De Rubeis, G.9 (AUTHOR), Lorusso, D.10 (AUTHOR), Floudas, C.5 (AUTHOR), Gulley, J.L.5 (AUTHOR), Apolo, A.B.4 (AUTHOR), Lee, J-M.11 (AUTHOR), Karzai, F.4 (AUTHOR), Altamura, V.1 (AUTHOR), Scambia, G.2 (AUTHOR), Daniele, G.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS956-S957. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.1647 |
